| Literature DB >> 34000290 |
Eduardo Duarte-Silva1, Michel Gomes de Melo2, Michael Maes3, Adriano José Maia Chaves Filho4, Danielle Macedo5, Christina Alves Peixoto6.
Abstract
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease with symptoms that go beyond the domain of glucose metabolism. In fact, research has shown that T2DM is accompanied by neurodegeneration and neuroinflammation. Interestingly, Major Depressive Disorder (MDD), a mood disorder characterized mainly by depressed mood and anhedonia is a key feature of T2DM. A body of evidence demonstrates that there are many shared neuroimmune mechanisms underlying the pathophysiology of T2DM and MDD. Therefore, here we review the state-of-art regarding the underlying factors common to both T2DM and MDD. Furthermore, we briefly discuss how depressive symptoms in diabetic patients could be tackled by using novel therapeutic approaches uncovered by these shared mechanisms. Understanding the comorbidity of depression in diabetic patients is essential to fully address T2DM pathophysiology and treatment.Entities:
Keywords: Major Depressive Disorder; Pathogenesis; Therapies; Type 2 Diabetes Mellitus
Mesh:
Substances:
Year: 2021 PMID: 34000290 DOI: 10.1016/j.pnpbp.2021.110351
Source DB: PubMed Journal: Prog Neuropsychopharmacol Biol Psychiatry ISSN: 0278-5846 Impact factor: 5.067